Novel Anti-Inflammatory Therapies in Coronary Artery Disease and Acute Coronary Syndromes

Y Dimitroglou, C Aggeli, P Theofilis, P Tsioufis… - Life, 2023 - mdpi.com
anti-inflammatory therapies are presented in Table 1. The use of anti-inflammatory therapies
… that these therapies have favorable anti-inflammatory effects and can reduce the hazard of …

[HTML][HTML] Anti-inflammatory therapy in coronary artery disease: where do we stand?

J Rakocevic, M Dobric, ML Borovic… - … in Cardiovascular …, 2023 - ncbi.nlm.nih.gov
… from its lipid-lowering or anti-inflammatory effect. The only way to prove inflammatory
hypothesis and anti-inflammatory approach in coronary artery disease was to test an agent that …

Anti-inflammatory therapies for coronary heart disease: a systematic review and meta-analysis

H Wang, M Jiang, X Li, Y Zhao, J Shao, Z Liu… - … in cardiovascular …, 2021 - frontiersin.org
… , we showed that anti-inflammatory agents yield mild cardiovascular protective effects but
result … However, further subgroup analysis demonstrated that multiple anti-inflammatory agents …

Safety and efficacy of anti-inflammatory therapy in patients with coronary artery disease: A systematic review and meta-analysis

Y Niu, N Bai, Y Ma, PY Zhong, YS Shang… - … Cardiovascular Disorders, 2022 - Springer
… have suggested that anti-inflammatory therapy can inhibit the atherosclerotic process, the
efficacy of anti-inflammatory therapy for patients with coronary artery disease (CAD) is still …

The anti-inflammatory effects of statins on coronary artery disease: an updated review of the literature

E Diamantis, G Kyriakos… - Current cardiology …, 2017 - ingentaconnect.com
… the effect of statin therapy on patients with stable coronary artery disease, and their results
have shown a positive correlation between the therapy and the disease outcome. A study by …

[HTML][HTML] Anti-inflammatory therapy for cardiovascular disease

CE Kosmas, D Silverio, A Sourlas… - Annals of …, 2019 - ncbi.nlm.nih.gov
… The LoDoCo (low-dose colchicine) trial was a prospective, randomized trial, which evaluated
532 patients with stable coronary artery disease (CAD), of which 282 were treated with …

Effects of anti-inflammatory medications in patients with coronary artery disease: a focus on losmapimod

B Tun, WH Frishman - Cardiology in Review, 2018 - journals.lww.com
… that the treatment course was limited in duration, and as a result one cannot preclude the
possibility that losmapimod may have efficacy as part of a longer anti-inflammatory therapy. …

Modifiable lifestyle risk factors and C-reactive protein in patients with coronary artery disease: Implications for an anti-inflammatory treatment target population

C Blaum, FJ Brunner, F Kröger, J Braetz… - European journal of …, 2021 - academic.oup.com
… The recent CANTOS trial provided proof of principle of specific anti-inflammatory treatment
on cardiovascular outcomes in patients with coronary artery disease (CAD) and a high …

Anti-inflammatory therapy for coronary atherosclerotic heart disease: unanswered questions behind existing successes

J Ma, X Chen - Frontiers in Cardiovascular Medicine, 2021 - frontiersin.org
… on inflammation and coronary artery disease. The results showed that anti-inflammatory
therapy might become an important tool for optimizing existing coronary drug therapy. However, …

Anti-inflammatory agents in peripheral arterial disease

AS Antonopoulos, E Papanikolaou, G Vogiatzi… - Current opinion in …, 2018 - Elsevier
… of anti-inflammatory agents for the treatment of atherosclerotic disease, including peripheral
arterial disease. … on the pleiotropic anti-inflammatory properties of approved drugs for use in …